Cementos Bio Bio S.A. (SNSE:CEMENTOS)
1,730.00
0.00 (0.00%)
Inactive · Last trade price on May 19, 2026
Cementos Bio Bio Ratios and Metrics
Market cap in millions CLP. Fiscal year is January - December.
Millions CLP. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 457,102 | 457,102 | 423,018 | 174,386 | 171,215 | 184,978 | |
Market Cap Growth | 13.47% | 8.06% | 142.58% | 1.85% | -7.44% | -5.60% |
Enterprise Value | 538,838 | 548,267 | 541,337 | 289,474 | 293,175 | 284,349 |
Last Close Price | 1730.00 | 1730.00 | 1601.00 | 595.56 | 562.52 | 534.30 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 13.81 | 13.82 | 13.05 | 7.65 | 16.21 | 6.88 |
PS Ratio | 1.23 | 1.23 | 1.18 | 0.50 | 0.51 | 0.64 |
PB Ratio | 1.58 | 1.58 | 1.56 | 0.68 | 0.71 | 0.72 |
P/TBV Ratio | 1.70 | 1.70 | 1.68 | 0.74 | 0.77 | 0.78 |
P/FCF Ratio | 9.79 | 9.79 | 7.79 | 7.24 | 18.26 | 47.92 |
P/OCF Ratio | 7.62 | 7.62 | 6.37 | 4.13 | 7.39 | 7.16 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.45 | 1.48 | 1.51 | 0.83 | 0.88 | 0.98 |
EV/EBITDA Ratio | 6.84 | 9.15 | 10.11 | 6.02 | 12.14 | 9.39 |
EV/EBIT Ratio | 11.97 | 12.17 | 13.80 | 8.30 | 25.68 | 16.64 |
EV/FCF Ratio | 11.55 | 11.75 | 9.96 | 12.02 | 31.27 | 73.66 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.43 | 0.43 | 0.52 | 0.48 | 0.51 | 0.48 |
Debt / EBITDA Ratio | 1.58 | 1.58 | 2.04 | 1.99 | 3.23 | 3.02 |
Debt / FCF Ratio | 2.66 | 2.66 | 2.61 | 5.11 | 13.10 | 31.72 |
Net Debt / Equity Ratio | 0.28 | 0.28 | 0.43 | 0.43 | 0.46 | 0.32 |
Net Debt / EBITDA Ratio | 1.35 | 1.35 | 2.17 | 2.28 | 4.64 | 2.69 |
Net Debt / FCF Ratio | 1.74 | 1.74 | 2.13 | 4.54 | 11.96 | 21.06 |
Asset Turnover | 0.71 | 0.71 | 0.71 | 0.72 | 0.69 | 0.62 |
Inventory Turnover | 4.35 | 4.35 | 4.14 | 3.80 | 4.58 | 5.05 |
Quick Ratio | 0.87 | 0.87 | 0.75 | 0.78 | 0.68 | 1.19 |
Current Ratio | 1.38 | 1.38 | 1.29 | 1.47 | 1.42 | 1.85 |
Return on Equity (ROE) | 11.83% | 11.83% | 12.29% | 9.16% | 4.23% | 10.80% |
Return on Assets (ROA) | 5.36% | 5.36% | 4.84% | 4.51% | 1.48% | 2.28% |
Return on Invested Capital (ROIC) | 10.04% | 9.93% | 8.24% | 8.31% | 3.30% | 4.20% |
Return on Capital Employed (ROCE) | 11.20% | 11.20% | 9.70% | 8.90% | 3.00% | 4.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 7.24% | 7.24% | 7.67% | 13.07% | 6.17% | 14.53% |
FCF Yield | 10.21% | 10.21% | 12.85% | 13.81% | 5.47% | 2.09% |
Dividend Yield | 4.62% | - | 5.00% | 6.04% | 2.13% | 8.98% |
Payout Ratio | 0.42% | 0.42% | 83.52% | 29.13% | 236.50% | 82.26% |
Total Shareholder Return | 4.62% | - | 5.00% | 6.04% | 2.13% | 8.98% |